Pfizer begins trial of COVID drug Paxlovid in kids 6 to 17
Pfizer Inc. announced Tuesday that it has launched a Phase 2/3 clinical trial of its COVID antiviral pill known as Paxlovid in children ages 6-17.Anews releasefrom the company said the tri
Updated on: February 24,2024
12
Pfizer begins trial of COVID drug Paxlovid in kids 6 to 17
Pfizer Inc. announced Tuesday that it has launched a Phase 2/3 clinical trial of its COVID antiviral pill known as Paxlovid in children ages 6-17.Anews releasefrom the company said the tri
Updated on:February 24,2024
12
